Oct 24, 2018
Esco Aster Singapore is now a member of the international Bio-Process System Alliance (BPSA), an industry group promoting the implementation of single-use systems for biotherapeutic and vaccine manufacturing.
Based in the Asia Pacific region, Esco Aster welcomes the increased trade opportunities and exposure that BPSA membership confers. By joining BPSA and its other 57 corporate members, Esco Aster will also become part of an expanding alliance to push forward the adoption of single-use systems.
“Esco Aster is privileged to be the first Asia-Pacific-Headquartered company to join BPSA. With this affiliation, Esco Aster plans to work with BPSA towards incorporating single-use systems into traditional and integrated systems around bio-processing” said Xiangliang Lin, Esco Aster's Chief Executive Officer.
“We welcome Esco Aster into BPSA membership. Along with our North American and European members, we hope to now expand our goal of advancing the adoption of single-use systems into Asia, by promoting the benefits of polymer-based bio-processing platforms across all continents” said Kevin Ott, BPSA’s Executive Director, based in Washington, DC.
About Esco Group
Esco Group’s vision is to invent, discover, and commercialise enabling technologies to make human lives healthier and safer. Esco Group is a Singapore-based life sciences ecosystem builder comprising over 30 companies, 1000 employees, with proprietary products and services sold in 100 countries.
Esco Aster is a contract development and manufacturing organisation (CDMO) focusing on offering vaccine-, cell- and gene-therapy development and biomanufacturing services using its proprietary Tide Motion technology, bioprocessing and bioengineering equipment.
For more information, visit www.escoaster.com.
Esco Aster Pte Ltd
21 Changi South Street 1
T: +65 6542 0833
The Bio-Process Systems Alliance (BPSA) was formed in 2005 as an industry-led corporate member trade association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, sharing of best practices, development of consensus guides and business-to-business networking opportunities among its member company employees. For more information, please visit www.bpsalliance.org, or contact Kevin Ott, Executive Director, at email@example.com.